Related Experiment Videos
The Role of Worst-Case Scenarios in Sponsors' and Regulators' Decision Making
1Therapeutic Innovation & Regulatory Science.
Therapeutic Innovation & Regulatory Science
|February 22, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Drug-induced proarrhythmia: Discussion and considerations for clinical practice.
JAAPA : official journal of the American Academy of Physician Assistants·2020
How to Prescribe Drugs With an Identified Proarrhythmic Liability.
Journal of clinical pharmacology·2019
Bowel Preparations for Colonoscopy: A Regulatory Perspective.
Therapeutic innovation & regulatory science·2018
Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes.
Therapeutic innovation & regulatory science·2018
Analysis of IMPD Deficiencies in the Clinical Trial Approval Process.
Therapeutic innovation & regulatory science·2026
Lean-Agile Product Development in FDA Relevant and Regulated Medical Device Contexts.
Therapeutic innovation & regulatory science·2026
Regulatory Reliance in Latin America: Opportunities and Implementation Challenges for International Pharmaceutical Companies.
Therapeutic innovation & regulatory science·2026
Current Landscape of Investigator-Initiated Decentralized Clinical Trials in Japan: A Nationwide Survey.
Therapeutic innovation & regulatory science·2026
Beyond prediction: an evidenced-based framework for assessing site selection decisions.
Therapeutic innovation & regulatory science·2026
Contribution of Real-World Evidence for the Orphan Medicines Approvals in the European Union Between 2000 and 2025.
Therapeutic innovation & regulatory science·2026